Literature DB >> 15727985

The influence of breast self-examination on subsequent mammography participation.

Susan E Jelinski1, Colleen J Maxwell, Jay Onysko, Christina M Bancej.   

Abstract

OBJECTIVES: We evaluated whether breast self-examination (BSE) influences subsequent mammography participation.
METHODS: We evaluated associations between BSE and subsequent mammography participation, adjusting for baseline screening behaviors and sociodemographic, health, and lifestyle characteristics, among women aged 40 years and older using data from the longitudinal Canadian National Population Health Survey.
RESULTS: Regular performance of BSE at baseline was not associated with receipt of a recent mammogram at follow-up among all women (adjusted odds ratio [OR]=1.01; 95% confidence interval [CI]= 0.75, 1.35) or with mammography uptake among the subgroup of women reporting never use at baseline (adjusted OR=0.78; 95% CI=0.50, 1.22).
CONCLUSIONS: The lack of association between performance of BSE and subsequent mammography participation suggests that not recommending BSE is unlikely to influence mammography participation.

Entities:  

Mesh:

Year:  2005        PMID: 15727985      PMCID: PMC1449210          DOI: 10.2105/AJPH.2003.032656

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  46 in total

1.  Breast self-examination.

Authors:  Ellen Warner
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

2.  Breast self-examination.

Authors:  Lauri Winters
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

3.  Breast self-examination.

Authors:  Shelley Snell
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

4.  Breast self-examination.

Authors:  Anthony B Miller; Cornelia Baines; Bart Harvey
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

5.  Breast self-examination.

Authors:  Leo Mahoney
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

6.  Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.

Authors:  A L Verbeek; J H Hendriks; R Holland; M Mravunac; F Sturmans; N E Day
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

7.  Contribution of clinical breast examination to mammography screening in the early detection of breast cancer.

Authors:  C Bancej; K Decker; A Chiarelli; M Harrison; D Turner; J Brisson
Journal:  J Med Screen       Date:  2003       Impact factor: 2.136

8.  Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Linda L Humphrey; Mark Helfand; Benjamin K S Chan; Steven H Woolf
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

9.  Randomized trial of breast self-examination in Shanghai: final results.

Authors:  David B Thomas; Dao Li Gao; Roberta M Ray; Wen Wan Wang; Charlene J Allison; Fan Liang Chen; Peggy Porter; Yong Wei Hu; Guan Lin Zhao; Lei Da Pan; Wenjin Li; Chunyuan Wu; Zakia Coriaty; Ilonka Evans; Ming Gang Lin; Helge Stalsberg; Steven G Self
Journal:  J Natl Cancer Inst       Date:  2002-10-02       Impact factor: 13.506

10.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

View more
  2 in total

1.  Is Canadian women's breast cancer screening behaviour associated with having a family doctor?

Authors:  Barbara Poole; Charlyn Black; Karen Gelmon; Lisa Kan
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275

2.  Factors influencing mammography participation in Canada: an integrative review of the literature.

Authors:  K Hanson; P Montgomery; D Bakker; M Conlon
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.